Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion type Assertion NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_head.
- NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion description "[Twelve of 17 (70.5%) localized tumors, 9/13 (69.2%) tumors with lymph node involvement and 9/11 (82.2%) tumors with distant metastases showed decreased or absent DCC expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_provenance.
- NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion evidence source_evidence_literature NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_provenance.
- NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion SIO_000772 9112574 NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_provenance.
- NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion wasDerivedFrom befree-20140225 NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_provenance.
- NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_assertion wasGeneratedBy ECO_0000203 NP796189.RAtxfbxm1rTEnYyeDgmNyKAKNyvLmN9di8yGWa-jmNjhE130_provenance.